159 related articles for article (PubMed ID: 27685905)
1. Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer.
Karatas F; Sahin S; Erdem GU; Ates O; Babacan T; Akin S; Sever AR; Ozisik Y; Altundag K
J BUON; 2016; 21(4):851-858. PubMed ID: 27685905
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
3. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
4. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
6. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
7. [The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].
Zhang W; Qi XM; Chen AX; Zhang P; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):374-379. PubMed ID: 28535656
[No Abstract] [Full Text] [Related]
8. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
Ma X; Yang X; Yang W; Shui R
Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
[TBL] [Abstract][Full Text] [Related]
9. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
[TBL] [Abstract][Full Text] [Related]
10. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
11. A clinical study to assess the pathological involvement of occult supraclavicular lymphnode metastasis in case of locally advanced operable breast carcinoma.
Virani SJ; Patni S; Shah R
Indian J Cancer; 2015; 52(3):282-5. PubMed ID: 26905111
[TBL] [Abstract][Full Text] [Related]
12. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
Reddy SG; Kiel KD
Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
[TBL] [Abstract][Full Text] [Related]
16. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
[TBL] [Abstract][Full Text] [Related]
17. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.
Sakao Y; Miyamoto H; Oh S; Takahashi N; Sakuraba M
J Thorac Oncol; 2007 Dec; 2(12):1107-11. PubMed ID: 18090583
[TBL] [Abstract][Full Text] [Related]
19. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
